 "Dr Reddy's launches high cholesterol drug in US market")
Dr Reddy's fenofibrate capsules USP, approved by the US FDA, is a therapeutic equivalent generic version of ANTARA capsules of Lupin Atlantis Holdings SA Corporation. The 43 mg capsules are available in bottle counts of 30 and 130 mg in bottle counts of 30 and 90, the company said in a filing to the BSE on Wednesday.
According to IMS Health's national sales perspective, the ANTARA capsules brand and generic had US sales of approximately $74 million for the 12 months ending February 2014.
Dr Reddy's scrip is currently trading at Rs 2,577.15 on the BSE, up 0.96%, over the previous close of Rs 2,552.70 a share.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app